SEM Q1 Earnings Call: Regulatory Headwinds and Mixed Division Performance Shape Outlook
Healthcare services company Select Medical (NYSE:SEM) missed Wall Street's revenue expectations in Q1 CY2025 as sales rose 2.4% year on year to $1.35 billion. The company's full-year revenue guidance of $5.4 billion at the midpoint came in 1.6% below analysts' estimates. Its GAAP profit of $0.44 per share was 7.3% below analysts' consensus estimates.
Is now the time to buy SEM? Find out in our full research report (it's free).
Revenue: $1.35 billion vs analyst estimates of $1.39 billion (2.4% year-on-year growth, 2.6% miss)
EPS (GAAP): $0.44 vs analyst expectations of $0.47 (7.3% miss)
Adjusted EBITDA: $151.4 million vs analyst estimates of $166.5 million (11.2% margin, 9.1% miss)
The company dropped its revenue guidance for the full year to $5.4 billion at the midpoint from $5.5 billion, a 1.8% decrease
EPS (GAAP) guidance for the full year is $1.14 at the midpoint, beating analyst estimates by 1.8%
EBITDA guidance for the full year is $520 million at the midpoint, below analyst estimates of $531.3 million
Operating Margin: 8.3%, in line with the same quarter last year
Free Cash Flow was -$55.8 million compared to -$119.2 million in the same quarter last year
Sales Volumes fell 1.9% year on year (1% in the same quarter last year)
Market Capitalization: $1.96 billion
Select Medical's first quarter results reflected the company's ongoing transition following the Concentra spin, with divergent trends across its main business lines. Management attributed the quarter's performance to robust growth in the inpatient rehabilitation division, which offset challenges in both outpatient and critical illness recovery hospital operations. CEO Robert Ortenzio cited severe weather events and Medicare reimbursement reductions as primary pressures on outpatient results, while regulatory changes and a delayed flu season weighed on the critical illness recovery segment.
Looking ahead, management's guidance is shaped by ongoing regulatory uncertainty and shifting payer dynamics. The team expressed cautious optimism about inpatient rehabilitation expansion, noting a strong development pipeline and recent facility openings. However, they acknowledged persistent headwinds in the critical illness recovery segment, including higher outlier thresholds and the impact of the 20% transmittal rule. Management stated, "We are constantly having conversations both on the regulatory side with the new CMS administration and on the legislative side," underscoring the unpredictable reimbursement environment.
Select Medical's leadership focused on the mixed performance across its divisions and the external factors impacting results. Management highlighted division-specific drivers and detailed ongoing initiatives to mitigate recent headwinds and support future growth.
Inpatient Rehab Outperformance: The inpatient rehabilitation division delivered double-digit revenue and EBITDA growth, supported by both increased daily rates and a robust pipeline of new facility openings and expansions. Management pointed to occupancy rates above 80% in mature hospitals and a multi-year plan to add 440 new beds.
Regulatory Headwinds in Critical Illness Recovery: The critical illness recovery hospital segment faced regulatory challenges, particularly a sharp increase in the high cost outlier threshold and the 20% transmittal rule. Management estimated these changes accounted for two-thirds of the EBITDA decline for this segment, and noted ongoing discussions with the Centers for Medicare & Medicaid Services (CMS) to address these impacts.
Outpatient Division Weather Disruption: Severe winter storms in key geographies and a 3% decline in Medicare reimbursement led to lower outpatient volumes and EBITDA. The division saw a late-quarter recovery, and management expects further improvements as technology and access initiatives progress.
Technology and Margin Initiatives: Management emphasized ongoing investments in technology for the outpatient business, including a new software platform aimed at improving productivity and contract negotiations. Early benefits were observed, and management expects margin improvement as further releases are implemented.
Strategic Capacity Management: The company continued to optimize its outpatient footprint by opening 10 new clinics and closing or consolidating 13 underperforming locations, aligning resources with market demand and supporting more efficient operations.
Management's outlook for the remainder of the year centers on regulatory and reimbursement trends, the pace of rehab expansion, and operational improvements in challenged segments.
Regulatory Uncertainty Remains: The company's earnings trajectory will depend on future CMS policy changes impacting critical illness recovery reimbursement, as well as ongoing advocacy to mitigate outlier threshold increases and transmittal rule effects.
Rehabilitation Expansion Pipeline: A strong pipeline of new inpatient rehab facilities and bed additions is expected to drive segment growth, with management noting both signed projects and additional opportunities under evaluation.
Margin Recovery Initiatives: Continued implementation of technology upgrades and productivity measures in the outpatient division are expected to support gradual margin improvement, although external factors such as weather and Medicare rates remain risks.
Justin Bowers (Deutsche Bank): Asked about expected occupancy rates in new inpatient rehab facilities. Management guided for occupancy to remain above 85% in mature hospitals, even as new capacity comes online.
Ben Hendrix (RBC Capital Markets): Inquired about mitigation strategies for regulatory headwinds in critical illness recovery hospitals. Management indicated active discussions with CMS and ongoing advocacy, but cautioned that policy changes may take time.
William Sutherland (The Benchmark Company): Sought clarification on the magnitude and timing of high cost outlier impacts and start-up costs. Management confirmed that start-up losses remained consistent year over year, with most headwinds concentrated in the first six weeks of the quarter.
William Sutherland (The Benchmark Company): Asked about outpatient margin improvement initiatives. Management described new technology rollouts and improved commercial contract rates as key drivers, with incremental benefits expected throughout the year.
Anne Hines (Mizuho): Asked about potential acceleration in inpatient rehab expansion to diversify away from critical illness recovery. Management confirmed an acceleration beyond currently announced projects, citing a robust project pipeline and ongoing market evaluations.
In the coming quarters, the StockStory team will monitor (1) regulatory developments and any CMS decisions related to reimbursement for critical illness recovery, (2) progress on opening new inpatient rehab facilities and the pace at which they reach targeted occupancy, and (3) the effectiveness of technology and operational initiatives aimed at restoring outpatient division margins. Additionally, trends in patient volumes and reimbursement rates across all segments will remain key indicators of business momentum.
Select Medical currently trades at a forward P/E ratio of 13×. Should you double down or take your chips? See for yourself in our free research report.
The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.
While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
5 Money Moves the Middle Class Should Make as Elon Musk Steps Down From DOGE
Elon Musk is scaling back his involvement with the Department of Government Efficiency (DOGE) to refocus on his business ventures, which have taken a hit in recent months. Read Next: Find Out: While DOGE lacks formal agency status and congressional backing, Musk's reduced role may still signal a shift in political focus around federal cost-cutting. For middle-class Americans, this shift is worth watching, especially as new budget proposals, potential changes to the federal tax code and debates over entitlements take center stage. Here are five money moves the middle class should make as Musk steps down from his leadership role at DOGE. Even as Elon Musk scales back from DOGE, government spending cuts are moving forward — just not in the way many, including Musk, had hoped. President Donald Trump's 'One Big Beautiful Bill' cuts funding for key public programs like housing, education and food assistance, while boosting defense and infrastructure spending. For the middle class, that means less support from government programs and no meaningful tax relief. For example, according to the Tax Policy Center, middle-income households would receive an average tax cut of about $1,800, or about 2.4% of their after-tax income, under the bill. In contrast, households in the top 5% of earners would see their tax bill cut by an average of $21,000, or 4.3% of their after-tax income. Now is the time for households to review their household budget and plan for potential gaps. Households and individuals who rely on tax credits, student aid or healthcare subsidies should prepare for potential changes and explore ways to build financial resilience in case these safety nets are reduced or eliminated. Be Aware: Given the potential for policy shifts and economic volatility, it's prudent for middle-class households to bolster their emergency savings. Financial experts commonly recommend setting aside three to six months' worth of living expenses to navigate unforeseen challenges, such as unexpected expenses or income disruptions resulting from changes in federal programs or economic downturns. According to experts at Vanguard, 'If you spend $5,000 per month, your first emergency fund savings milestone should be $2,500 to cover spending shocks. For your longer-term goal of an emergency fund that will cover income shocks, aim to save $15,000 to $30,000 total.' DOGE's initiatives included attempts to reform entitlement programs. Although Musk has stepped back, discussions around modifying Social Security and Medicare continue. For example, according to an analysis by the Medicare Rights Center, an advocacy organization, earlier versions of Trump's bill included proposals that 'would strip health coverage from nearly nine million people with Medicaid and Affordable Care Act plans.' Healthcare advocates also said, 'CBO (Congressional Budget Office) projected that taken together, these proposals would cause 13.7 million people to become uninsured.' However, the final number of how many people could lose healthcare coverage hasn't yet been tallied. Middle-class Americans, especially those nearing retirement, should stay informed about potential changes and consider consulting financial planners to understand how adjustments might impact their retirement plans. Without Musk, DOGE layoffs could still have a significant impact on the economy. Cresset Capital market analysts found that 'the ultimate economic impact will depend on the final scale of workforce reductions, the ability of the private sector to absorb workers and whether government service disruptions affect broader economic activity.' With uncertainties surrounding federal policies, the same market analysts recommended 'maintaining a diversified portfolio and a long-term investment horizon.' Specifically, middle-class investors should also consider a diversified portfolio of assets, including stocks, bonds and other instruments, to protect against market volatility and policy-driven economic fluctuations. Understanding the implications of federal initiatives like DOGE is essential for middle-class Americans. By staying informed and consulting a financial advisor, individuals can better anticipate policy changes instead of reacting to the latest headlines. A well-informed perspective enables proactive decision-making and strengthens the ability to advocate for policies that reflect their financial interests and long-term goals. Editor's note on political coverage: GOBankingRates is nonpartisan and strives to cover all aspects of the economy objectively and present balanced reports on politically focused finance stories. You can find more coverage of this topic on More From GOBankingRates Mark Cuban Tells Americans To Stock Up on Consumables as Trump's Tariffs Hit -- Here's What To Buy 10 Unreliable SUVs To Stay Away From Buying This article originally appeared on 5 Money Moves the Middle Class Should Make as Elon Musk Steps Down From DOGE Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
What Medicare doesn't pay for becomes hefty debt for millions of seniors
Connie Morton's husband died last November. The cause: complications from Parkinson's disease, which he had been living with for 18 years. 'During that time, there were multiple medical costs not covered by Medicare,' the Colonial Beach, Va., resident told Yahoo Finance. 'We paid what we could. For the last nine years of his life, he could no longer work. I became his caretaker, and we survived on Social Security and some help from his kids.' A growing number of retirees, like Morton, are grappling with healthcare debt due to medical bills. Medicare, which provides health insurance coverage to more than 66 million people, covers the lion's share of the cost of medical care, but not all. On average, a 65-year-old who left the workforce last year may need $165,000 in savings to cover out-of-pocket healthcare expenses throughout retirement. Earlier this year, Morton broke her ankle. 'That also added up to significant hospital bills,' she said. The combination of medical bills not covered by Medicare for the retired couple: roughly $90,000. 'I'm at a point now where I can't keep my house because the bills are much too high,' Morton said. 'I'm trying to decide what I'm going to do.' One in 10 people age 65 or older with healthcare debt owe $10,000 or more, according to a KFF study. 'That is a shocking number,' said Tricia Neuman, senior vice president of KFF. 'Some of it is credit card debt, some of it is just debt owed to a healthcare provider or a hospital. Some of it is debt to other family members.' Consider that half of all people on Medicare live on about $35,000 or less, Neuman added. 'So a $10,000 bill, or $10,000 worth of medical debt, can really be unaffordable for people and have serious consequences.' The bills that lead to the debt typically include routine healthcare services such as lab fees and diagnostic tests, dental care, and visits to the doctor, and long-term care services not covered by Medicare, according to KFF. Medicare often requires patients to pay out of pocket around 20% of their doctor bills. 'In-home care for people who are unable to take care of themselves and don't have family members that can drop everything to be there 24/7, is particularly big,' she added. 'It's a variety of healthcare expenses that can pile up and lead to medical debt.' One of the biggest culprits of credit card debt is out-of-pocket medical costs. The amount that people borrow increases dramatically with age. Half of adults 50 and older who report borrowing money to pay for healthcare in the past 12 months borrowed approximately $3,000 or more, according to a new West Health-Gallup healthcare survey. In contrast, the median amount was $750 for adults aged 30-49 and $300 for young adults aged 18-29. 'People often have higher healthcare expenses as they age, for things like dental, vision care, prescription medication, and doctor visits,' said Lori Trawinski, AARP's senior director of finance and employment. 'In many cases, healthcare costs are often charged on credit cards, which can lead to carrying that debt from month to month,' she said. That's real trouble. Anyone who has rolled over credit card balances is keenly aware of the debt that accrues when you can only pay the minimum on credit cards with interest rates topping 20%. Troubling, too, is that many people on Medicare say that they or another member of their household have delayed, skipped, or sought alternatives to needed healthcare or prescription medications due to costs, KFF found. Read more: The best ways to pay off credit card debt Anqi Chen, co-author of a brief from the Center for Retirement Research at Boston College, recently surveyed retirees with $100,000 in investable assets. 'They were largely unprepared for a medical shock,' she learned. One driver is that traditional Medicare and Medicare Advantage do not cover the cost of long-term care in nursing homes and assisted-living facilities. An apartment in an assisted-living facility had an average rate of $74,148 a year in 2024, according to the National Investment Center for Seniors Housing & Care — and costs go up as residents age and need more care. Units for dementia patients can run more than $94,000. 'If these shocks are big enough, they can devastate a household's finances,' Chen said. 'About 80% of those ages 65 and over will require some long-term care, with nearly 20% requiring high-intensity care for more than three years.'Here are some moves that can help you manage your money and avoid medical debt. Plan for healthcare expenses It's important to make healthcare costs a part of your budget and factor potential unexpected healthcare costs in your emergency fund, said Carolyn McClanahan, a certified financial planner and physician. Medicare's online searchable Plan Finder on the site allows you to review plan options. If you have a limited income, you might be eligible for Medicare's Extra Help, which covers Part D premiums and deductibles and caps drug costs. And for now, free one-on-one counseling is available through state Health Insurance Assistance Programs. Read more: What is an emergency savings fund? Don't be shy If you're having issues affording your care, ask your doctor if there is anything more cost-effective, such as changing medications or going to other facilities for testing, McClanahan said. 'And make sure you understand why your doctor is ordering tests and what they plan to do with the information. Sometimes they order tests based on 'protocol' and aren't really needed,' she added. Consult a financial adviser If you have a health shock, your financial adviser can help with a plan by reviewing your overall assets, cash flow, liquidity, and where you can rebalance investments to free up cash to cover future bills. Build a health savings account (HSA) If you're retiring soon, maximizing HSA contributions can be a smart move. An HSA lets you put money in on a tax-free basis, lets that money build up tax-free, and lets it come out tax-free for qualified healthcare expenses. (Some states assess state taxes.) In order to put money into an HSA, you must be enrolled in a high-deductible health plan. In those plans, you pay a lower premium per month than other types of health insurance plans, but a heftier annual deductible. Read more: HSA contribution limits for 2025: Here's how much you can save Check your credit report Get a free copy of your credit reports from In January, the Consumer Financial Protection Bureau (CFPB) finalized a rule that bans the inclusion of medical bills on credit reports used by lenders and prohibits lenders from using medical information in their lending decisions Each of the three big credit bureaus — Equifax, Experian, and Transunion — provides these free once a year. Check for accuracy and be certain that it does not include medical debt. If you see a mistake, contact the credit bureau to report it and get it removed. Read more: 6 benefits of a good credit score Scrutinize medical bills and negotiate if need be Ask for a line-item list of charges from your providers. Mistakes happen. It might be possible to set up a low-interest payment plan with the hospital or medical provider. Credit card issuers might also lower your interest rate if you have a good track record of timely payments before the medical crisis. Tap retirement accounts If you're over 59½, you can pull from your tax-deferred accounts penalty-free, although you will pay tax on the amount you withdraw. For many people, this is a speedy way to eliminate debt. However, it comes with a red-light caveat: Using your retirement accounts to whittle down debt depletes your retirement savings, and you miss out on the possibility of returns on those invested dollars. Work with a counselor A nonprofit credit counselor may also be able to negotiate with your credit card issuers if your medical debt is part of a credit card balance. You will pay a fee for the service. The Justice Department website provides a list of approved credit counseling agencies. One source to get started: National Foundation for Credit Counseling Declare bankruptcy No one really wants to go there. But if there's no relief in sight for your medical debt, this can be a do-over. A bankruptcy attorney can walk through the details with you. In general, retirement accounts are off the table during bankruptcies under federal law. Pensions, 401(k)s, 403(b)s, SEP-IRAs, and qualified profit-sharing plans are exempt from creditors. Traditional and Roth individual retirement accounts worth up to roughly $1.7 million are also protected. Social Security payments are also exempt. Kerry Hannon is a Senior Columnist at Yahoo Finance. She is a career and retirement strategist and the author of 14 books, including the forthcoming "Retirement Bites: A Gen X Guide to Securing Your Financial Future," "In Control at 50+: How to Succeed in the New World of Work" and "Never Too Old to Get Rich." Follow her on Bluesky. Sign up for the Mind Your Money newsletter
Yahoo
3 hours ago
- Yahoo
Down 24%, Should You Buy the Dip on BigBear.ai?
The company's share price is down as it struggles to deliver revenue growth. The company isn't profitable despite the best efforts of multiple CEOs. The artificial intelligence analytics market is still promising. 10 stocks we like better than › Many companies that sell artificial intelligence (AI) services have seen their share price skyrocket over the past couple of years. AI data analytics company (NYSE: BBAI) has seen significant volatility, but it has also benefited from bullish market sentiment. The company's share price has surged 142% over the past 12 months, dwarfing the 11% return of the S&P 500. That said, it has also lost a lot of ground lately with a 24% decline in just the past three months. The recent dip no doubt has some investors wondering if this is a great time to buy stock or a warning sign to stay away. The company still has a lot to prove, and here are three reasons investors should leave this AI stock alone right now. Small companies that are tapping into such a fast-growing and in-demand market like AI should experience rapid sales growth. And yet BigBear managed to increase its revenue just 5% year over year to $34.8 million in the most recent quarter. Unfortunately, this appears to be a pattern for the company. Revenue was flat in 2023 and up just 2% in 2024. This year, management says sales could increase 7% (at the midpoint of its guidance). That's unimpressive growth for such a young AI company. For comparison's sake, fellow AI data analytics company Palantir Technologies grew sales 29% last year to $2.9 billion. Typically, high-growth companies experience lots of top-line expansion early on, and investors hope that momentum eventually leads to profits. But with sales growth has been missing for years. reported an adjusted EBITDA loss of $7.0 million in the first quarter, which was worse than its loss of $1.6 million in the year-ago quarter. Management said costs were primarily driven by increased research and development expenses as well as recurring selling, general, and administrative (SG&A) costs. In either case, the company can't afford to have these expenses continue to outpace sales. For investors hoping profits will soon follow the same pattern as its astronomical share price returns over the past couple of years, it's likely to be a very long wait. This may not be the typical reason investors should steer clear of a company, but it certainly raises some red flags. Leadership is crucial to a company's success, so it's worrying to see under its third CEO since it went public in 2021. The current CEO, Kevin McAleenan, has only been at the helm since January. He was the acting Secretary of the U.S. Department of Homeland Security during the first Trump administration. This government connection has some investors hoping that will be able to secure more government contracts. But what they should really be hoping for is McAleenan to stick around long enough to be able to execute a long-term vision for the company. When you add up the company's leadership changes, weak sales growth, and continued losses, it's clear to me the stock is not a buy right now. In a market full of compelling AI stocks, there simply isn't much that's appealing about a speculative bet on Before you buy stock in consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $651,049!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $828,224!* Now, it's worth noting Stock Advisor's total average return is 979% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 19, 2025 Chris Neiger has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool has a disclosure policy. Down 24%, Should You Buy the Dip on was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
